Exodus Point Capital Management, LP F Star Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.77 - $5.36 $30,065 - $58,177	-10,854 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.71 - $7.38 $51,122 - $80,102	10,854 New	10,854 $54,000
Q3 2021 Nov 15, 2021	SELL	$5.2 - $8.42 $103,760 - $168,012	-19,954 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $131,097 - $213,707	19,954 New	19,954 $171,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.